Stock PHARM PHARMING GROUP N.V.
Add to a list
To use this feature you must be a member
Log inSign up

News Pharming Group N.V.

Equities

PHARM

NL0010391025

Market Closed - Euronext Amsterdam
Other stock markets
 11:35:58 2024-05-08 am EDT 		5-day change 1st Jan Change
0.879 EUR -1.79% Intraday chart for Pharming Group N.V. +0.29% -14.74%
May. 08 Pharming Group N.V. Provides Revenue Guidance for 2024 CI
May. 08 Pharming Group N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Pharming Group N.V., Q1 2024 Earnings Call, May 08, 2024
Pharming N : 1Q 2024 Financial Results Presentation - May 8, 2024
PU
Pharming Group reports first quarter 2024 financial results and provides business update
AQ
Pharming Group reports first quarter 2024 financial results and provides business update
GL
Pharming Group N.V. Provides Revenue Guidance for 2024
CI
Pharming Group N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Pharming N : Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025 - Form 6-K
PU
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders 2024 Rare Impact Awards
AQ
Pharming N : to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards - Form 6-K
PU
Pharming N : Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards
PU
Pharming Group to report first quarter 2024 financial results on May 8
GL
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards
GL
Pharming Group to Buy Back EUR123 Million of Bonds due 2025
MT
Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025
GL
Pharming N : Pharming Group announces the placement of €100 million convertible bonds due 2029
PU
Pharming Group announces the placement of €100 million convertible bonds due 2029
GL
Pharming Group to Issue EUR100 Million Convertible Bonds, Repurchase EUR125 Million Bonds
MT
Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025
GL
Pharming Group N.V. announced that it expects to receive ?100 million in funding
CI
Pharming Group N.V. Announces Completion of Enrollment in Pediatric Clinical Trial of Leniolisib
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PHARM Stock
  4. News Pharming Group N.V.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW